SY

Healthcare · Pharmaceuticals

Symbiotec Pharmalab Ltd (SYMBIOTEC)

₹1,598.60

Mkt cap
₹10,354 Cr
P/E ratio
70.00
P/B
7.54
Div yield
0.00%
ROE
11.70%
ROCE
13.00%
EPS (TTM)
₹22.84
Book value
₹212
52W range
934–1,665
Sector
Healthcare

Price history

Previous close

Symbiotec is a research-driven, science- based pharmaceutical and biotechnology company with a strong global leadership position in Corticosteroid and Steroidal Hormone Active Pharmaceutical Ingredients (APIs). It has evolved from a Lab-Scale Steroid manufacturer into a fully integrated global platform. [1]

NSE SYMBIOTECBSE 544889
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−3.98% from high
₹1,599
₹934+71.12% from low₹1,665
Current
₹1,598.60
Prev close
₹1,604.80
Day
−0.39%
Price performance
1D
+0.06%
1W
−0.34%
1M
+34.10%
3M
—
6M
—
1Y
—
YTD
+45.63%

Financials

Revenue, profit & margin
P/E ratio
70.0×
SYMBIOTEC is 106% above the sector median of 34.0×
SYMBIOTEC70.0×
Sector median34.0×
 Jun 2025Sep 2025Mar 2026Jun 2026Sep 2026Trend
Sales203196245218280
YoY Sales growth+7%+43%
Expenses145145183173188
Operating Profit5850624592
OPM %29%26%25%21%33%
Other Income30000
Interest56766
Depreciation1111202222
Profit before tax4533351864
Tax %33%43%22%20%19%
Net Profit3019281452
EPS in Rs46.9930.184.392.248.05
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +8.00% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast21 Sept '26◦5 Nov '26◦
Earnings day−3.04%+19.04%
+1 day−8.14%+22.27%
+5 days−1.03%+23.75%
+15 days+8.40%—
+30 days+10.29%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
33.28%Promoter
Promoters33.28%
FIIs3.79%
DIIs33.17%
Public29.77%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Symbiotec Pharma₹1,611.3070.0410,3540.00%52+169.15%280+43.17%12.99%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings